Judy H. Cho, MD, is the Director of the Charles Bronfman Institute for Personalized Medicine (CBIPM), the Ward-Coleman Chair for Translational Genetics, and the Vice-Chair for Research in Gastroenterology at the Icahn School of Medicine at Mount Sinai. She is an international authority on IBD genetics and disease mechanisms and is leading efforts in developing novel translational approaches to study IBD.
Dr. Cho has served as Chair of the Steering Committee and Principal Investigator of the Data Coordinating Center of the NIH-funded NIDDK IBD Genetics Consortium since 2003. In this capacity, she has led efforts in the identification of over 200 genetic regions associated to IBD. Since 2015, Dr. Cho has led the CBIPM, which includes the School’s major biobank, named BioMe. This biobank includes samples and matched medical record information on a highly diverse cohort of over 39,000 Mount Sinai Health System patient volunteers, involving over 850,000 separate biospecimens. BioMe and CBIPM reflect the School’s major commitment to Precision or personalized medicine to improve the care of patients on an individualized basis.